Sirolimus as Long-term Graft-versus-host-disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplant Recipients for Non-malignant Disorders is Associated with High Incidence of Acneiform Lesions

BACKGROUND: Sirolimus has provided the option for calcineurin inhibitor (CNI)-free immunosuppressive therapy in both solid organ transplant (SOT) and hematopoietic stem cell transplantation (HSCT). However, long-term use of sirolimus has been reported to be associated with a high incidence of cutane...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakrbarti, Aditi, Jaiswal, Sarita Rani, Chakrabarti, Suparno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681198/
https://www.ncbi.nlm.nih.gov/pubmed/26677273
http://dx.doi.org/10.4103/0019-5154.169131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681198/
https://www.ncbi.nlm.nih.gov/pubmed/26677273
http://dx.doi.org/10.4103/0019-5154.169131

Ejemplares similares